Sitewide buy two, get one free is live — Made in USA — Same-day fulfilment on orders before 2pm
Product image unavailable
Currently unavailable
For Research Use Only. Not for human or animal use.
Published reports linked to this product. Consult the original certificate for the reported methods and scope.
Latest linked report
Lot
C84913
Analysis date
2026-05-14
Sample received
2026-05-11
Recorded values; see the original report for methods and qualifiers.
Net peptide content
Ipamorelin: 5.96 mg; CJC-1295 (mod GRF 1-29): 5.37 mg
Identity
Ipamorelin; CJC-1295 (mod GRF 1-29)
Open an earlier linked certificate to inspect its lot, date and recorded results.
Janoshik Analytical
Lot
C30175
Analysis date
2025-07-17
Net peptide content
CJC-1295 (mod GRF 1-29): 5.10 mg; Ipamorelin: 6.21 mg
Original report file unavailable.
This research compound is provided in lyophilized form and packaged in a 3ml vial to ensure stability and reliable handling. CJC-1295/Ipamorelin is prepared for research settings that require precise materials for controlled studies.
Supplied as lyophilized powder for extended stability
Packaged in a 3ml vial
Suitable for a variety of laboratory research studies
